OSI Systems (OSIS) Q3 2026 earnings review
Record Backlog Masks Severe Cash Flow Squeeze and Healthcare Woes
OSI Systems delivered a highly mixed Q3. The headline numbers look resilient: non-GAAP EPS grew 7% to a record $2.60, and total backlog swelled to a record $1.9 billion on a strong 1.3x book-to-bill ratio. However, underlying earnings quality is deteriorating. Total revenue growth decelerated to just 2% YoY, severely weighed down by the planned wind-down of lucrative Mexico contracts and a floundering Healthcare division. The most glaring red flag is the 82% YoY collapse in Operating Cash Flow to just $14.5 million—a stark contradiction to management's earlier promises of 'outsized' cash conversion from delayed Mexico receivables. Reversing this cash squeeze and achieving the reiterated FY26 guidance will require a massive, flawless execution ramp in Q4.
🐂 Bull Case
A 1.3x book-to-bill ratio pushed the backlog to a record $1.9 billion. Excluding the Mexico headwind, core Security revenues surged 25% YoY, proving demand for the company's broader product portfolio remains robust.
The Optoelectronics & Manufacturing segment continues to post stable, double-digit growth (+10% YoY) as OEMs actively de-risk their supply chains away from China toward OSI's facilities in Mexico and Southeast Asia.
🐻 Bear Case
Operating cash flow plunged 82% YoY. Management previously pointed to $837M in accounts receivable (largely from Mexico) as a catalyst for FY26 cash flow. The Q3 failure to convert these receivables to cash is a major unfulfilled promise.
The Healthcare division is in freefall. Revenues declined 7% YoY, and GAAP operating margins have violently reversed from +3.0% a year ago to -5.8% today.
⚖️ Verdict: 🔴
Bearish. While the $1.9B backlog and core security growth (ex-Mexico) secure the long-term story, the acute failure to collect cash, ballooning restructuring costs, and a collapsing Healthcare segment make the immediate fundamentals highly questionable.
Key Themes
Operating Cash Flow Collapse Contradicts Management Narrative
In previous quarters, management heavily promoted the narrative that FY26 would see 'outsized free cash flow conversion' exceeding net income, driven by the collection of massive delayed receivables from Mexico. Q3 directly contradicts this: Operating Cash Flow plunged 82% YoY to just $14.5M, while CapEx grew to $7.6M. This liquidity squeeze forces questions about the true collectability and timeline of the Mexico backlog.
Healthcare Division Profitability is Reversing Rapidly
The Healthcare division has shifted from a slow turnaround to an active liability. Revenues decelerated by 7% YoY to $40.7M. Worse, operating leverage collapsed: GAAP operating margin plunged to a dismal -5.8% (an operating loss of $2.4M), completely reversing the 3.0% positive margin from the same quarter last year. The turnaround strategy is clearly failing to gain traction in the near term.
Core Security Growth Thriving Despite Mexico Wind-down
Top-line Security division growth decelerated to a stagnant +1% YoY ($319.3M). However, this masks a very bullish underlying trend: the expected roll-off of massive Mexico contracts. When stripping out the Mexico headwind, the broader security portfolio (aviation, RF detection, cargo) is accelerating at a 25% YoY clip. The 1.3x consolidated book-to-bill ratio further proves global demand is intact.
Optoelectronics Sustaining Supply Chain Shift Momentum
The Optoelectronics & Manufacturing segment remains stable and robust, growing 10% YoY to $111.0M. Operating margins held steady at 13.2%. The division continues to act as a direct beneficiary of global macro trends: OEMs are actively diversifying their supply chains away from China to avoid tariffs, funneling demand toward OSI's vertically integrated footprint in Mexico and Asia.
GAAP vs Non-GAAP Quality of Earnings Divergence
While non-GAAP EPS grew 7%, GAAP EPS actually declined 3% to $2.33. The gap is widening largely due to a spike in 'Impairment, restructuring and other charges,' which nearly tripled YoY from $2.3M to $6.2M in Q3. Investors should closely monitor these 'one-time' expenses, as they are becoming a recurring drag on real profitability.
Macro Risks Specifically Cited in Guidance
Management explicitly cited the 'recent shutdown of the Department of Homeland Security' and 'current conflicts in the Middle East' as potential headwinds to near-term bookings and revenue. While the $1.9B backlog provides a buffer, any freeze in DHS funding deployment directly threatens the aggressive Q4 ramp required to meet FY26 guidance.
Other KPIs
Accelerating. Up from $1.8 billion at the end of Q2 FY26. Driven by a massive Q3 book-to-bill ratio of 1.3x, this provides the company with exceptional multi-year revenue visibility, entirely validating the structural demand for their core security and RF offerings.
Reversing negatively. Charges accelerated significantly from $2.25M in the prior year quarter. Year-to-date, the company has burned $11.7M on restructuring compared to just $3.6M in the prior year period. These continuous 'adjustments' are heavily propping up the Non-GAAP EPS beat.
Stable. Gross profit effectively flat-lined at $150.3M vs $150.3M last year, with margins contracting slightly from 33.8% in Q3 FY25. The high-margin Mexico revenue roll-off is capping margin expansion despite growth in the higher-margin services business.
Guidance
Stable. The company maintained its full-year guidance. However, doing the math reveals a steep climb: to hit the $1.846B midpoint, OSI must deliver approximately $544M in Q4 revenue. This implies an aggressive acceleration to ~8% YoY growth in Q4, a stark leap from Q3's anemic 2% growth.
Stable for the year, but implying a massive Q4 acceleration. Year-to-date Non-GAAP EPS sits at $6.60. To reach the $10.42 midpoint, Q4 must yield $3.82 in EPS—an 18% YoY surge compared to Q4 FY25's $3.24.
Key Questions
Where are the Mexico Collections?
Operating cash flow fell 82% YoY in Q3. In previous quarters, you assured investors that the massive delayed accounts receivable from Mexico would convert to outsized free cash flow this fiscal year. What specifically has delayed these collections, and are there any concessions being made to secure them?
Healthcare Division Profitability Bridge
The Healthcare segment reported an operating margin of -5.8% this quarter, a severe deterioration from positive margins last year. Is this driven by one-time investments, or structural pricing/volume issues? What is the specific timeline to return this division to profitability?
DHS Shutdown Risk to Backlog
You cited the recent Department of Homeland Security shutdown as a potential impact factor. How much of the record $1.9 billion backlog is currently tethered to unfunded or delayed DHS/CBP mandates, and could this jeopardize the steep $544M revenue ramp implied for Q4?